slu-pp-332 with retatrutide The Synergistic Duo: Retatrutide &

Treatment with GLP1 Receptor Agonists Reduce Serum CRP Concentrations in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Results after 8 weeks: Body weight: 8.1% Waist circumference: 8.2% Testosterone: 128.5% (more than doubled) Estrogen: 60.8% Group B Testosterone (TRT) + Lifestyle Medication Used: Transdermal testosterone gel (AndroGel 1.62%) Starting Dose: 23 mg/day, applied to the upper arms/shoulders for the first 14 days

While its helpful for blood sugar control, people usually dont lose much weight, if any, while taking it

The STEP 1 trial, published in the New England Journal of Medicine , demonstrated that participants receiving semaglutide 2.4 mg weekly lost an average of 14.9 percent of their body weight over 68 weeks, compared to 2.4 percent with placebo (Wilding et al., 2021)